| Dainippon Sumitomo Pharma Co., Ltd. was established by the merger of Dainippon Pharmaceutical and Sumitomo Pharmaceuticals as of October 1, 2005. Our corporate mission is “to broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide”. We are firmly determined to satisfy medical needs in the society with a wide variety of products in such therapeutic areas as (i) CNS (central nervous system), (ii) cardiovascular and diabetes, (iii) inflammation, immunology and allergy, and (iv) oncology and infection. Our company is also doing business in such fields as veterinary products and feed additives by leveraging propriety technologies which we have gained from pharmaceutical business. |
